Busch, Michael P.

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Sabino, E. C., Buss, L. F., Carvalho, M. P. S., Prete, C. A., Crispim, M. A. E., Fraiji, N. A., Pereira, R. H. M., Parag, K. V., da Silva Peixoto, P., Kraemer, M. U. G., et al. (2021) · The Lancet

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 758

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

Buss, L. F., Prete, C. A., Abrahim, C. M. M., Mendrone, A., Salomon, T., de Almeida-Neto, C., França, R. F. O., Belotti, M. C., Carvalho, M. P. S. S., Costa, A. G., et al. (2021) · Science

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 488

Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study.

Terrault, N. A., Dodge, J. L., Murphy, E. L., Tavis, J. E., Kiss, A., Levin, T. R., Gish, R. G., Busch, M. P., Reingold, A. L., & Alter, M. J. (2013) · Hepatology

Hepatitis C virus researchHIV, Drug Use, Sexual Risk

Cited by 263

Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020–May 2021

Jones, J. M., Stone, M., Sulaeman, H., Fink, R. V., Dave, H., Levy, M. E., Di Germanio, C., Green, V., Notari, E., Saa, P., et al. (2021) · JAMA

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 201

The consequences of temporary deferral on future whole blood donation

Custer, B., Chinn, A., Hirschler, N. V., Busch, M. P., & Murphy, E. L. (2007) · Transfusion

Blood donation and transfusion practicesNonprofit Sector and Volunteering

Cited by 185

Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses

Pulko, V., Davies, J. S., Martinez, C., Lanteri, M. C., Busch, M. P., Diamond, M. S., Knox, K., Bush, E. C., Sims, P. A., Sinari, S., et al. (2016) · Nature Immunology

T-cell and B-cell ImmunologyImmunotherapy and Immune Responses

Cited by 175

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Peluso, M. J., Takahashi, S., Hakim, J., Kelly, J. D., Torres, L., Iyer, N. S., Turcios, K., Janson, O., Munter, S. E., Thanh, C., et al. (2021) · Science Advances

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 130

Genomic Epidemiology Reconstructs the Introduction and Spread of Zika Virus in Central America and Mexico

Thézé, J., Li, T., du Plessis, L., Bouquet, J., Kraemer, M. U. G., Somasekar, S., Yu, G., de Cesare, M., Balmaseda, A., Kuan, G., et al. (2018) · Cell Host & Microbe

Mosquito-borne diseases and controlViral Infections and Vectors

Cited by 106

Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study

Erikstrup, C., Laksafoss, A. D., Gladov, J., Kaspersen, K. A., Mikkelsen, S., Hindhede, L., Boldsen, J. K., Jørgensen, S. W., Ethelberg, S., Holm, D. K., et al. (2022) · The Lancet Regional Health - Europe

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 60